EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of microglia in Alzheimer's disease and progress of treatment

Yi-Huan Guan iD, Ling-Jing Zhang iD, Shi-Ya Wang iD, Ya-Dan Deng, Hong-Su Zhou, Dong-Qing Chen, Lan-Chun Zhang

Ibrain · 2022-03 · 8 (1) · 37-47

DOI: 10.1002/ibra.12023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ibrain, online erschienen am 22.02.2022. Verfasst von Yi-Huan Guan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology Zunyi Medical University Zunyi Guizhou China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia are permanent immune cells of the central nervous system. Microglia play an important role in the pathological process of Alzheimer's disease (AD). They are mainly involved in the uptake and clearance of amyloid‐β (Aβ), as well as the formation of neuroinflammation. We found that overactivated microglia increase Aβ and Tau, and Aβ and Tau in turn act as activators of microglia. Additionally, various cytokines and proteins, high cholesterol, and telomere shortening are all associated with microglia activation. More activated microglia induce the release of inflammatory and anti‐inflammatory factors to regulate inflammation, while microglia express multiple homologous receptors that bind to neuroimmunomodulators to prevent microglia overactivation. Moreover, aging of the body promotes neuroinflammation by increasing the response to IFN‐γ (interferon‐γ), and aging of the microglia themselves promotes AD by inducing the accumulation of large amounts of iron and reducing autophagy by regulating protein levels. Cognitive dysfunction occurs when activated microglia induce an increase in beta oligomers, promoting the production of pro‐inflammatory factors that alter the shape, composition, and density of synapses. Based on their correlation, microglia‐mediated AD therapy as well as the corresponding targets and drugs are discussed. In contrast to similar reviews, this article also summarizes some novel microglia‐mediated AD treatment methods over the recent years.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer diseaseaginggrowth and developmentmicroglia

Autor:innen und Institutionen

  • Department of Anesthesiology Zunyi Medical University Zunyi Guizhou China.
  • Department of Anesthesia Graduate School of Zunyi Medical University Zunyi Guizhou China.
  • Department of Zoology Kunming Medical University Kunming China.

ORCID-Profile: Yi-Huan Guan, Ling-Jing Zhang, Shi-Ya Wang

Zitieren

APA

Guan, Y. H., Zhang, L. J., Wang, S. Y., Deng, Y. D., Zhou, H. S., Chen, D. Q., & Zhang, L. C. (2022). The role of microglia in Alzheimer's disease and progress of treatment. Ibrain, 8(1), 37-47. https://doi.org/10.1002/ibra.12023

Vancouver

Guan YH, Zhang LJ, Wang SY, Deng YD, Zhou HS, Chen DQ, et al. The role of microglia in Alzheimer's disease and progress of treatment. Ibrain. 2022;8(1):37-47. doi:10.1002/ibra.12023

BibTeX
@article{Guan2022,
  author = {Guan, Yi-Huan and Zhang, Ling-Jing and Wang, Shi-Ya and Deng, Ya-Dan and Zhou, Hong-Su and Chen, Dong-Qing and Zhang, Lan-Chun},
  title = {The role of microglia in Alzheimer's disease and progress of treatment},
  journal = {Ibrain},
  year = {2022},
  volume = {8},
  number = {1},
  pages = {37--47},
  doi = {10.1002/ibra.12023}
}
Kostenlos starten →